Dr. Saver joined Astrocyte Pharmaceutical’s Scientific Advisory Board in December of 2018, and Chairs Astrocyte’s Clinical Advisory Board. He has been the Director of the UCLA Stroke Unit since its inception in 1995, and he is Professor and SA Vice-Chair of Neurology at the David Geffen School of Medicine at UCLA. He is a global leader in cerebrovascular research and clinical care. Dr. Saver has been the global or site principal investigator for more than 50 clinical research studies including the groundbreaking studies FAST-MAG, SWIFT-PRIME, and DAWN. He also Co-Chairs the Acute Stroke Trial Working Group for the NIH-NINDS StrokeNet National Stroke Trials Network.
Dr. Saver’s research focuses on stroke prevention, stroke diagnosis, acute stroke treatment, and neurocognitive and neurobehavioral consequences of stroke. He has published more than 500 original articles, more than 30 book chapters, and two edited volumes. Dr. Saver also served as Chair of the American Heart Association Stroke Council. He currently is Associate Editor at JAMA, the Journal of the American Medical Association, and Editorial Board Member at the journal Circulation. Dr. Saver received his medical degree from Harvard Medical School, did his internship at Brigham & Women’s Hospital and his residency at Brigham & Women’s Hospital, and is a graduate of the Harvard-Longwood Neurology Training Program, the University of Iowa Fellowship Program in Behavioral Neurology and Cognitive Neuroscience, and the Brown University Fellowship Program in Vascular Neurology.
